Arkolith/Insider Trading/MLTX/Form 4

Bodenstedt Matthias

Chief Financial OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Oct 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2023Disposed to issuer(D)63K——294K
Oct 1, 2023Conversion(C)63K——621K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2023Conversion(C)2K——9K

Transaction Codes

D
Disposition to the issuer
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001013762-23-001300) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML